Second, miR-146a inhibition might have facilitated specific inflammation-relevant mRNAs such as CFH, interleukin-1 receptor-associated kinase 1, and tetraspanin-12, which inhibited the release of pro-inflammatory cytokines and decreased sustained inflammation in both AD models extensively (11,18). This evidence concerns the gene TSPAN12 and Alzheimer disease.